Holista Colltech Limited · ASX:HCT
Holista Colltech — Shareholder Meeting (May 2025)
13 slides from Holista Colltech's shareholder meeting presentation, May 30, 2025
Slide 1: Presentation from AGM and Clarification on Nano-Collagen Licensing Agreement
Holista Colltech Limited (ASX:HCT / ABN 24 094 515 992) 283 Rokeby Road Subiaco WA 6008 P: +61 412 474 180 W: www.holistaco.com 30 May 2025 Presentation from AGM and Clarification on Nano-Collagen Licensing Agreement Holista Colltech Limited (ASX: HCT) (“Holista” or the “Company”) advises that the a
Slide 2: FY2024 Annual General Meeting (AGM)
For personal use only FY2024 Annual General Meeting (AGM) Perth, Australia 29 May 2025
Slide 3: Disclaimer
Disclaimer This document has been prepared by Holista Colltech Limited and comprises written material/slides for a presentation concerning Holista Colltech Limited and its subsidiaries. For personal use only The presentation is for information purposes only and does not constitute or form part of an
Slide 4: Agenda
Agenda For personal use only ▪ Recent Corporate Developments ▪ FY2024 Financial Highlights ▪ Update of Collagen Business ▪ Forward Strategy & Outlook ▪ AGM Resolutions 3 FY 2024 AGM Presentation
Slide 5: Recent Corporate Developments
Recent Corporate Developments For personal use only Second & final Recent Changes to payment of $900K to Funds from 2 the Board – KK Lai as settle ASIC penalty Converting Notes – Mr Leong Man Independent completed on 12 $1.53M received in Loong (ED) Chairman, 2 Non- March 2025 (fulfilled March 2025
Slide 6: 2024 Financial Highlights
2024 Financial Highlights For personal use only Revenue: $5.6M (decrease from $5.9M in FY2023 due to market challenges/ product mix) Net Loss After Tax: -$87k, significantly improved from -$4.9M in FY2023. Recovered debt of $560K and $534K from trade receivables; reversal of provisions related to le
Slide 7: Chronology of Recent Developments
Chronology of Recent Developments For personal use only 2024 2024 2025 2025 2025 2025 2025 2025 19 Mar 14 Nov 28 Feb 12 Mar 1 Apr 16 Apr 27 May 29 May Issue of Release of Update on Federal Converting FY’24 Annual Collagen Court verdict 1st Payment of Business Notes 2nd Payment of Report Resignation
Slide 8: Business Segments
Business Segments For personal use only Dietary Supplements Infection Control & Food Ingredients ▪ Malaysian dietary Agriculture ▪ Major products are supplements market formulas for low-sugar ▪ In FY2025, this division valued at USD 644.88M in and flour mix to lower expanded to include 2023, project
Slide 9: Collagen Segment – Update
Collagen Segment – Update For personal use only 01 02 03 04 Production at Collie ceased after expiry New facility will of lease; adopt modular, reinstatement asset-light approach Sufficient buffer stock completed on 1 Nov Will be scalable and using sea containers to meet business 2024; Applied to mo
Slide 10: Nano-Collagen Related Developments
Nano-Collagen Related Developments For personal use only Targeting medical Partnered with Akrivis Also developing with Holista & Ultraverse applications, e.g. of India to develop Akrivis product for secured grant of wound healing & organ nano-collagen; Filed nano-collagen to be $163K from printing –
Slide 11: Proposal For Nano-Collagen & Exosome Facility in Sarawak
Proposal For Nano-Collagen & Exosome Facility in Sarawak For personal use only Holista has held several rounds of discussion with government of Sarawak state in Malaysia to establish dedicated production facility in biotech hub in Kuching Holista intends to form JV and avail itself to funding, regul
Slide 12: Licensing Agreement with U.S. Company Specialising in Wound Healing
Licensing Agreement with U.S. Company Specialising in Wound Healing For personal use only ▪ Regenerex has evaluated nano-collagen samples; believes it can provide major benefits for wound healing ▪ It is commencing clinical studies to use nano-collagen for wound healing, and filing regulatory approv
Slide 13: Thank You
For personal use only Thank You For further information, please contact: Corporate Matters: investors@holistaco.com General Enquiries: enquiries@holistaco.com